AstraZeneca (AZN) Tops Q1 EPS by 139c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NASDAQ: AZN) reported Q1 EPS of $2.49, $1.39 better than the analyst estimate of $1.10. Revenue for the quarter came in at $13.59 billion versus the consensus estimate of $13.77 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- National Bank Holdings (NBHC) PT Lowered to $43 at DA Davidson
- Nu Holdings (NU) spreaders of November 17 and 20 calls
- Increasing unusual call option volume: PAGS GFL UMC BBD STNE ACB XP GEVO ITUB NXH DNA OPTT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
